305 filings
Page 5 of 16
CORRESP
cy8qr
5 May 23
Correspondence with SEC
12:00am
UPLOAD
zyu8b 3el
4 May 23
Letter from SEC
12:00am
8-K
lo9iy
28 Apr 23
SAB Biotherapeutics Announces Positive Results from Phase 3 Trial of SAB-185 in Patients with COVID-19 at High-Risk for Severe Complications
9:04am
8-K
kp01 zwbzw
19 Apr 23
SAB Biotherapeutics Announces U.S. FDA Grants Breakthrough Therapy Designation to SAB-176 Influenza Immunotherapy
5:05pm
8-K
8eq5potc
14 Apr 23
Regulation FD Disclosure
8:58am
4
vd6bum7 qq1
5 Apr 23
SAB Biotherapeutics / Erick Lucera ownership change
5:01pm
3
4sz blm9v69u
5 Apr 23
SAB Biotherapeutics / Erick Lucera ownership change
5:00pm
8-K
r0lqr5lai7ko3l
4 Apr 23
SAB Biotherapeutics Announces Appointment of Erick Lucera, CFA to Board of Directors
9:34am
NT 10-K
bscwjd 7268ajcm
31 Mar 23
Notice of late annual filing
5:12pm
8-K
h4rbc7y
31 Mar 23
SAB Biotherapeutics Provides Company Update for Full Year 2022
5:12pm
8-K
8awfkhak97rk1qj
24 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:19pm
4
a9f0sw3p6cx rfc2
16 Mar 23
SAB Biotherapeutics / Alexandra Kropotova ownership change
4:30pm
4
1gjcxif rg6
16 Mar 23
SAB Biotherapeutics / Eddie Joe Sullivan ownership change
4:29pm
4
8replp ou2ez
16 Mar 23
SAB Biotherapeutics / Samuel J Reich ownership change
4:28pm
4
edb29lo
16 Mar 23
SAB Biotherapeutics / Christoph Lawrence Bausch ownership change
4:28pm
4
l77w8e
16 Mar 23
SAB Biotherapeutics / Russell P Beyer ownership change
4:27pm